| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 301.5 Million | USD 467.46 Million | 4.2% | 2024 |
FrequentlyAsked Questions
The chemical compound form of metformin is metformin hydrochloride which is used to control high blood sugar in patients with type 2 diabetes.
The global metformin hydrochloride market is expected to grow due to increasing prevalence of type 2 diabetes, rising geriatric population, growing demand for cost-effective oral antidiabetic therapies, and expanding adoption in emerging markets due to lifestyle changes and urbanization.
According to a study, the global metformin hydrochloride market size was worth around USD 301.5 Million in 2024 and is expected to reach USD 467.46 Million by 2034.
The global metformin hydrochloride market is expected to grow at a CAGR of 4.2% during the forecast period.
North America is expected to dominate the metformin hydrochloride market over the forecast period.
Leading players in the global metformin hydrochloride market include Shouguang Fukang Pharmaceutical, CR Double-Crane, Wanbury, Keyuan Pharmaceutical, Aarti Drugs, Farmhispania Group, Harman Finochem, Exemed Pharmaceuticals, Vistin Pharma, Shijiazhuang Polee Pharmaceutical, USV, among others.
The report explores crucial aspects of the metformin hydrochloride market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients